Enact Holdings

Enact's CRT/reinsurance program materially reduces balance-sheet volatility and preserves regulatory capital so the company can continue writing new insurance through stress periods. If true, Enact can sustain NIW and ROE through cycles without expensive capital raises; if false, a spike in losses could force curtailed writing, capital raises, or regulatory restrictions.

Proprietary loan-level underwriting and pricing discipline produce consistently positive underwriting performance such that earnings remain resilient even when NIW fluctuates. Sustained underwriting outperformance drives predictable earnings, supports a low multiple and funds capital returns; if underwriting weakens, earnings and cash flow will compress quickly.

GSE-approved status and a diversified customer base protect Enact's distribution so loss of a single large originator or normal competition won't materially depress NIW or revenue. Distribution durability sustains scale, underwriting diversification and margins; if distribution concentration breaks, NIW and revenue could fall quickly and capital returns would be endangered.

Enact converts underwriting profits into strong operating cash flow, enabling capital returns (dividends/buybacks) without jeopardizing capital adequacy. Reliable cash conversion funds shareholder returns and supports a lower-risk valuation; if cash conversion fails, the company must preserve capital and suspend returns or raise external capital.